Inogen, which manufactures portable oxygen concentrators, raised $71 million by offering 4.4 million shares at $16, the low end of the range of $16 to $18. Inogen plans to list on the NASDAQ under the symbol INGN. Inogen initially filed confidentially on 10/16/2013. J.P. Morgan was the sole bookrunner on the deal.
